Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 790635, 2 pages

Treatment of Liver Metastases in Patients with Neuroendocrine Tumors

1Division of Endocrine Oncology, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden
2Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
3Department of Gastroenterology and Clinical Medicine, St. James’s Hospital and Trinity College Dublin, Dublin, Ireland
4H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA

Received 25 December 2011; Accepted 25 December 2011

Copyright © 2012 Dan Granberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Sungkyoung Kim, Wenping Ding, Lian Zhang, Wei Tian, and Siyu Chen, “Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials,” Oncotargets and Therapy, vol. 7, pp. 719–728, 2014. View at Publisher · View at Google Scholar
  • Yooju Shin, Sang Yun Ha, Jiyeon Hyeon, Boram Lee, Jeeyun Lee, Kee-Taek Jang, Kyoung-Mee Kim, Young Suk Park, and Cheol-Keun Park, “Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute,” Cancer Research and Treatment, vol. 47, no. 4, pp. 738–746, 2015. View at Publisher · View at Google Scholar
  • Benedikt Feuerecker, Klemens Scheidhauer, Markus Schwaiger, and Mona Mustafa, “Intra-arterial radiopeptide therapy of hepatic metastases of neuroendocrine tumors: a systematic review,” Clinical and Translational Imaging, 2017. View at Publisher · View at Google Scholar